{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:15:44Z","timestamp":1787249744400,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"KBP BioSciences Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s13318-024-00879-3","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T14:03:04Z","timestamp":1707400984000},"page":"229-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics of\u00a0the\u00a0Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone (KBP-5074) in\u00a0Individuals with\u00a0Moderate Hepatic Impairment"],"prefix":"10.1007","volume":"49","clinical-trial-number":[{"clinical-trial-number":"nct04534699","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0297-0302","authenticated-orcid":false,"given":"James","family":"McCabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"issue":"10008","key":"879_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/s0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386(10008):2059\u201368. https:\/\/doi.org\/10.1016\/s0140-6736(15)00257-3.","journal-title":"Lancet"},{"issue":"8","key":"879_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/10641963.2011.566956","volume":"33","author":"X Zhou","year":"2011","unstructured":"Zhou X, Crook MF, Sharif-Rodriguez W, Zhu Y, Ruben Z, Pan Y, Urosevic-Price O, Wang L, Flattery AM, Forrest G, Szeto D, Zhao H, Roy S, Forrest MJ. Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension. Clin Exp Hypertens. 2011;33(8):538\u201347. https:\/\/doi.org\/10.3109\/10641963.2011.566956.","journal-title":"Clin Exp Hypertens"},{"issue":"23","key":"879_CR3","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2025845.","journal-title":"N Engl J Med"},{"issue":"2","key":"879_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","volume":"42","author":"R Agarwal","year":"2021","unstructured":"Agarwal R, Kolkhof P, Bakris G, Bauersachs J, Haller H, Wada T, Zannad F. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J. 2021;42(2):152\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa736.","journal-title":"Eur Heart J"},{"issue":"10","key":"879_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/13543784.2021.1985462","volume":"30","author":"B Pitt","year":"2021","unstructured":"Pitt B, Jaisser F, Bakris G. An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertension. Expert Opin Investig Drugs. 2021;30(10):1017\u201323. https:\/\/doi.org\/10.1080\/13543784.2021.1985462.","journal-title":"Expert Opin Investig Drugs"},{"key":"879_CR6","doi-asserted-by":"publisher","DOI":"10.16966\/2470-1009.137","author":"CP Chow","year":"2017","unstructured":"Chow CP, Liu JR, Tan XJ, Huang ZH. Pharmacological profile of KBP-5074, a novel nonsteroidal mineralocorticoid receptor antagonist for the treatment of cardiorenal diseases. J Drug Res Dev. 2017. https:\/\/doi.org\/10.16966\/2470-1009.137.","journal-title":"J Drug Res Dev"},{"issue":"6","key":"879_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/eurjhf\/hfs061","volume":"14","author":"B Pitt","year":"2012","unstructured":"Pitt B, Filippatos G, Gheorghiade M, Kober L, Krum H, Ponikowski P, Nowack C, Kolkhof P, Kim SY, Zannad F. Rationale and design of ARTS: a randomized, double-blind study of BAY 94\u20138862 in patients with chronic heart failure and mild or moderate chronic kidney disease. Eur J Heart Fail. 2012;14(6):668\u201375. https:\/\/doi.org\/10.1093\/eurjhf\/hfs061.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"879_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/hypertensionaha.121.17073","volume":"78","author":"G Bakris","year":"2021","unstructured":"Bakris G, Pergola PE, Delgado B, Genov D, Doliashvili T, Vo N, Yang YF, McCabe J, Benn V, Pitt B. Effect of KBP-5074 on blood pressure in advanced chronic kidney disease: results of the BLOCK-CKD study. Hypertension. 2021;78(1):74\u201381. https:\/\/doi.org\/10.1161\/hypertensionaha.121.17073.","journal-title":"Hypertension"},{"issue":"8","key":"879_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646\u20139. https:\/\/doi.org\/10.1002\/bjs.1800600817.","journal-title":"Br J Surg"},{"issue":"20","key":"879_CR10","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"key":"879_CR11","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for health-related research involving humans. Geneva, Switzerland; 2016."},{"key":"879_CR12","doi-asserted-by":"publisher","unstructured":"Dixon JR (198) The guideline. Qual Assur 6(2):65\u201374. Doi: https:\/\/doi.org\/10.1080\/105294199277860.","DOI":"10.1080\/105294199277860"},{"issue":"4","key":"879_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13318-023-00837-5","volume":"48","author":"P Wang","year":"2023","unstructured":"Wang P, Liu J, Tan X, Yang F, McCabe J, Zhang J. Pharmacokinetics and drug-drug interaction of ocedurenone (KBP-5074) in vitro and in vivo. Eur J Drug Metab Pharmacokinet. 2023;48(4):397\u2013410. https:\/\/doi.org\/10.1007\/s13318-023-00837-5.","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-024-00879-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-024-00879-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-024-00879-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T14:17:53Z","timestamp":1709216273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-024-00879-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1007\/s13318-024-00879-3","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"17 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding for this study and manuscript was provided by KBP BioSciences USA, Inc., Princeton, NJ, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors were employees of KBP Biosciences USA, Inc., Princeton, NJ, but have no other relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data and materials information can be made available upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Before the start of the study, the protocol, informed consent form, investigator\u2019s brochure, and other relevant documents were reviewed and approved by the appropriate Institutional Review Board. The study was conducted in accordance with the protocol and with the consensus ethical principles derived from international guidelines, including the Declaration of Helsinki [], the Council for International Organizations of Medical Sciences [], and the International Conference on Harmonization Good Clinical Practice Guideline [], as well as applicable laws and regulations.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All subjects provided informed consent before participation in this study.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Jay Zhang, James McCabe, and Fred Yang participated in the research design. Jay Zhang and James McCabe performed data analysis. James McCabe, Vincent Benn, Fred Yang, and Jay Zhang wrote or contributed to the writing of the manuscript. James McCabe provided medical oversight. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}